High Titer De Novo Donor-Specific HLA Alloantibodies and Cardiac Allograft Vasculopathy After Pediatric Heart Transplantation

被引：0
|
作者：
Das, B. [1 ]
Zhang, S. [2 ]
Gao, A. [2 ]
Lacelle, C. [3 ]
机构：
[1] UTSW Med Ctr, Div Cardiol, Dept Pediat, Dallas, TX USA
[2] UTSW Med Ctr, Dept Clin Sci Res, Dallas, TX USA
[3] UTSW Med Ctr, Dept Pathol, Dallas, TX USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
223
引用
收藏
页码：286 / 286
页数：1
相关论文
共 50 条
  • [41] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, Alev
    Oguz, Fatma Savran
    Usta, Sebahat
    Yildirim, Zeynep Yuruk
    Pehlivanoglu, Cemile
    Kekik, Cigdem
    Emre, Sevinc
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1724 - 1724
  • [42] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, A.
    Yildirim, Z. Yuruk
    Pehlivanoglu, C.
    Nayir, A.
    Emre, S.
    Savran, F. Oguz
    Usta, S.
    Kekik, C.
    PEDIATRIC TRANSPLANTATION, 2015, 19 : 125 - 125
  • [43] De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation
    Cole, Robert Townsend
    Gandhi, Jonathan
    Bray, Robert A.
    Gebel, Howard M.
    Morris, Alanna
    McCue, Andrew
    Yin, Michael
    Laskar, S. Raja
    Book, Wendy
    Jokhadar, Maan
    Smith, Andrew
    Duc Nguyen
    Vega, J. David
    Gupta, Divya
    CLINICAL TRANSPLANTATION, 2017, 31 (04)
  • [44] DYSLIPIDEMIA AND CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Simonenko, M.
    Sazonova, Y.
    Fedotov, P.
    Krasnov, V.
    Rubinchik, V.
    Pervunina, T.
    Berezina, A.
    Privorotskii, V.
    Zverev, D.
    Sitnikova, M.
    Nikolaev, G.
    Gordeev, M.
    Karpenko, M.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 11 - 11
  • [45] OBESITY AND CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Carr, S.
    Hamilton, M.
    Kobashigawa, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 158 - 158
  • [46] Analysis of de novo donor-specific HLA-DPB1 antibodies in kidney transplantation
    Tang, Chen
    Unterrainer, Christian
    Fink, Annette
    Cinca, Sofia
    Ruhenstroth, Andrea
    Scherer, Sabine
    Morath, Christian
    Zeier, Martin
    Mehrabi, Arianeb
    Suesal, Caner
    Thuong Hien Tran
    HLA, 2021, 98 (05) : 423 - 430
  • [47] STRENGTH/SPECIFICITY OF DE NOVO HLA DONOR-SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANTATION: CLINICAL SIGNIFICANCE
    Piazza, Antonina
    Poggi, Elvira
    Ozzella, Giuseppina
    Adorno, Domenico
    HUMAN IMMUNOLOGY, 2009, 70 : S64 - S64
  • [48] Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function
    Leech, SH
    Mather, PJ
    Eisen, HJ
    Pina, IL
    Margulies, KB
    Bove, AA
    Jeevanandam, V
    CLINICAL TRANSPLANTATION, 1996, 10 (06) : 639 - 645
  • [49] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES AFTER KIDNEY TRANSPLANTATION ARE ASSOCIATED WITH DONATION AFTER CIRCULATORY DEATH AND HLA-DQ MISMATCH
    Roelen, Dave
    Dreyer, Geertje
    Reinders, Marlies
    Brand, Simone
    Dekkers, Olaf
    Claas, Frans
    de Fijter, Hans
    TISSUE ANTIGENS, 2015, 85 (05): : 406 - 406
  • [50] Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation
    Grabhorn, Enke
    Binder, Thomas M. C.
    Obrecht, Denise
    Brinkert, Florian
    Lehnhardt, Anja
    Herden, Uta
    Peine, Sven
    Nashan, Bjoern
    Ganschow, Rainer
    Briem-Richter, Andrea
    TRANSPLANTATION, 2015, 99 (09) : 1876 - 1881
12345